U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H15F2N3O3S
Molecular Weight 331.338
Optical Activity ( + )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GENACONAZOLE, (R,R)-

SMILES

C[C@H]([C@](O)(CN1C=NC=N1)C2=C(F)C=C(F)C=C2)S(C)(=O)=O

InChI

InChIKey=HFGZFHCWKKQGIS-NOZJJQNGSA-N
InChI=1S/C13H15F2N3O3S/c1-9(22(2,20)21)13(19,6-18-8-16-7-17-18)11-4-3-10(14)5-12(11)15/h3-5,7-9,19H,6H2,1-2H3/t9-,13-/m1/s1

HIDE SMILES / InChI

Molecular Formula C13H15F2N3O3S
Molecular Weight 331.338
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Sch 39304 is a new broad-spectrum orally active triazole antifungal agent that is active, orally and topically, against a broad range of fungal pathogens, including superficial Trichophyton mentagrophytes and vaginal Candida albicans infections. The mechanism of action of SCH-39304 appears similar to those of ketoconazole and fluconazole, involving inhibition of cell membrane ergosterol synthesis. SCH-39304 has two asymmetrical carbon atoms, and the formulation used in clinical trials has been a racemic mixture of two enantiomers, active SCH-42427 (RR (+)-) and inactive SCH-424264 (SS (–)-). Unfortunately, hepatocarcinomas associated with the use of SCH-39304 in animals have sharply restricted the development and use of this agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
1990 Aug
Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.
1991 Sep
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
1992 May
Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi.
1993 Dec
Pneumocystis carinii is resistant to imidazole antifungal agents.
1994 Aug
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
1995 Jun
Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM-8668.
1996 Feb
Stereoselective interaction of the azole antifungal agent SCH39304 with the cytochrome P-450 monooxygenase system isolated from Cryptococcus neoformans.
1997 Jul

Sample Use Guides

200 mg once daily for 12 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:38:27 GMT 2023
Edited
by admin
on Fri Dec 15 15:38:27 GMT 2023
Record UNII
I87RHM3O1J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GENACONAZOLE, (R,R)-
Common Name English
1H-1,2,4-TRIAZOLE-1-ETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-((1R)-1-(METHYLSULFONYL)ETHYL)-, (.ALPHA.R)-
Systematic Name English
(.ALPHA.R)-.ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-((1R)-1-(METHYLSULFONYL)ETHYL)-1H-1,2,4-TRIAZOLE-1-ETHANOL
Common Name English
SCH-39304, (+)-
Code English
SCH-39304, (R,R)-
Code English
SCH-42427
Code English
SM-9164
Code English
1H-1,2,4-TRIAZOLE-1-ETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-.ALPHA.-(1-(METHYLSULFONYL)ETHYL)-, (R-(R*,R*))-
Common Name English
SM1964
Code English
SCH42427
Code English
Code System Code Type Description
FDA UNII
I87RHM3O1J
Created by admin on Fri Dec 15 15:38:27 GMT 2023 , Edited by admin on Fri Dec 15 15:38:27 GMT 2023
PRIMARY
PUBCHEM
452261
Created by admin on Fri Dec 15 15:38:27 GMT 2023 , Edited by admin on Fri Dec 15 15:38:27 GMT 2023
PRIMARY
CAS
121650-83-7
Created by admin on Fri Dec 15 15:38:27 GMT 2023 , Edited by admin on Fri Dec 15 15:38:27 GMT 2023
PRIMARY
EPA CompTox
DTXSID90923916
Created by admin on Fri Dec 15 15:38:27 GMT 2023 , Edited by admin on Fri Dec 15 15:38:27 GMT 2023
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER